✦ LIBER ✦

Consensus symposium on combined antiviral therapy; Overview of interferon and IL-2 combinations for the treatment of HIV infection

✍ Scribed by Michael C. Sneller

Book ID: 113259129
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 372 KB
Volume: 29
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(95)00930-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advances in the Treatment of Hepatitis C

Advances in the Treatment of Hepatitis C: Combination Antiviral Therapy With Interferon alfa-2b and Ribavirin

✍ Laura Benson; Alice Birkel; Linda Caldwell; Valerie Stafford-Fox; Beverley Casar 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Combined Interferon and Lamivudine Thera

Combined Interferon and Lamivudine Therapy: Is This The Treatment of Choice for Patients With Chronic Hepatitis B Virus Infection?

✍ Norah A. Terrault 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

The effect of pegylated interferon-alpha

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients

✍ Hiroki Nishikawa; Eriko Iguchi; Yorimitsu Koshikawa; Soichiro Ako; Tadashi Inuzu 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 162 KB

Combination of Fluoxetine and Cognitive

Combination of Fluoxetine and Cognitive Therapy for the Treatment of Major Depression Among People with HIV Infection: A Time-Series Analysis Investigation

✍ Josee Savard; Benoit Laberge; Janel G. Gauthier; Jean-Pierre Fournier; Stephane 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 334 KB

Combination therapy with thymosin α1 and

Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial

✍ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin ␣1 (TA1), an immunomodulatory peptide, to the standard tr

Early anemia and rapid virological respo

Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1

✍ Ahmad Amanzada; Simon Schneider; Federico Moriconi; Alexander Lindhorst; Thomas 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB